Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Atox Bio
55 Vilcom Center Drive, Suite 230
Chapel Hill, NC 27514
Phone: 919-636-7260
http://www.atoxbio.com/

Atox Bio is a late stage clinical biotechnology company that develops novel immune modulators for critically ill patients with severe infections. Atox Bio has an ongoing contract No. HHSO100201400013 with the Biomedical Advanced Research and Development Authority (BARDA) supporting the development of Reltecimod in NSTI. The Company was established by Prof. Raymond Kaempfer and Dr. Gila Arad from the Hebrew University of Jerusalem and Yissum.

Key Contact
Name
Dan Teleman
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/04/17 $30,000,000 Adams Street Partners
Arix Bioscience
Asahi Kasei
Integra Holdings
Lundbeckfond Ventures
OrbiMed Advisors
SR One
undisclosed